Lethargy In an Infant: Unfolded as Methyl Malonic Aciduria

Authors

  • Muhammad Usman Munir Department of Chemical Pathology, Armed Forces Institute of Pathology/ National University of Medical Sciences (NUMS), Rawalpindi Pakistan
  • Qurat Ul Ain Department of Chemical Pathology, Armed Forces Institute of Pathology/ National University of Medical Sciences (NUMS), Rawalpindi Pakistan
  • Muhammad Qaiser Alam Khan Department of Chemical Pathology, Armed Forces Institute of Pathology/ National University of Medical Sciences (NUMS), Rawalpindi Pakistan

DOI:

https://doi.org/10.51253/pafmj.v75i3.10685

Keywords:

Metabolic disorders, Organic aciduria

Abstract

Methyl malonic aciduria (MMA) is a rare inherited metabolic disorder characterized by the inability of the body to process certain proteins and fats properly and is primarily caused by mutations in genes involved in the metabolism of vitamin B12. Patients often exhibit symptoms such as failure to thrive, developmental delays, lethargy, dehydration, vomiting, and metabolic acidosis which can lead to severe complications, including neurological damage, kidney dysfunction, and even death. Diagnosis of methyl malonic aciduria involves measuring levels of methyl malonic acid in the blood and urine, along with genetic testing to identify the specific gene mutations responsible. Management requires dietary interventions aimed at restricting protein intake and supplementing with vitamin B12, however, in some cases, patients may require additional treatments, such as the administration of carnitine or medications that lower the levels of toxic metabolites.

Downloads

Download data is not yet available.

References

Wajner M, Vargas CR, Amaral AU. Disruption of mitochondrial functions and oxidative stress contribute to neurologic dysfunction in organic acidurias. Arch Biochem Biophys 2020; 696: 108646.

https://doi.org/10.1016/j.abb.2020.108646

Forny P, Hochuli M, Rahman Y, et al. Liver neoplasms in methylmalonic aciduria: an emerging complication. J Inherit Metab Dis 2019; 42(5): 793-802. https://doi.org/10.1002/jimd.12143

Levtova A, Waters PJ, Buhas D, et al. Combined malonic and methylmalonic aciduria due to ACSF3 mutations: benign clinical course in an unselected cohort. J Inherit Metab Dis 2019; 42(1): 107-116. https://doi.org/10.1002/jimd.12032

Brennerová K, Škopková M, Ostrožlíková M, et al. Genetic testing is necessary for correct diagnosis and treatment in patients with isolated methylmalonic aciduria: a case report. BMC Pediatr 2021; 21(1): 1-8. https://doi.org/10.1186/s12887-021-03067-3

Wood WD, Elmaghrabi A, Gotway G, et al. The roles of homocysteinemia and methylmalonic acidemia in kidney injury in atypical hemolytic uremic syndrome caused by cobalamin C deficiency. Pediatr Nephrol 2021; 1-4.

https://doi.org/10.1007/s00467-021-05372-6

Hwang N, Jang JH, Cho EH, et al. Prenatal diagnosis of combined methylmalonic acidemia and homocystinuria cobalamin C type using clinical exome sequencing and targeted gene analysis. Mol Genet Genomic Med 2021; 9(11): e1838.

https://doi.org/10.1002/mgg3.1838

Yu Y, Shuai R, Liang L, et al. Different mutations in the MMUT gene are associated with the effect of vitamin B12 in a cohort of 266 Chinese patients with mut-type methylmalonic acidemia: a retrospective study. Mol Genet Genomic Med 2021; 9(11): e1822.

https://doi.org/10.1002/mgg3.1822

Luciani A, Denley MC, Govers LP, et al. Mitochondrial disease, mitophagy, and cellular distress in methylmalonic acidemia. Cell Mol Life Sci 2021; 1-7.

https://doi.org/10.1007/s00018-021-03934-3

Downloads

Published

30-06-2025

Issue

Section

Case Reports

How to Cite

1.
Munir MU, Ain QU, Khan MQA. Lethargy In an Infant: Unfolded as Methyl Malonic Aciduria. Pak Armed Forces Med J [Internet]. 2025 Jun. 30 [cited 2025 Jul. 7];75(3):617-9. Available from: https://pafmj.org/PAFMJ/article/view/10685